NanoViricides Confirms It Has Been Working On A Treatment For The Novel Wuhan Coronavirus

Author's Avatar
Jan 31, 2020
Article's Main Image

SHELTON, CT / ACCESSWIRE / January 30, 2020 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, is confirming public disclosures in articles by various industry journals and other articles, that it is working on developing a treatment for the novel coronavirus 2019-nCoV, or the Wuhan coronavirus.